Compare
NAVs as of 20 Aug 2026
Add a second fund to compare. Until then every figure below is shown against the Large & Mid Cap Fund median (36 funds), which is the only comparison one fund can support.
Growth of ₹100 (rebased over the selected window)
Common period 28 Nov 2016 – 20 Aug 2026. Every series is rebased to ₹100 at the start of this window. Benchmark lines are the category index WealthTicker measures against, which is not always the benchmark the scheme itself declares — the fund page’s Scheme Info names that one. Nifty Midcap 150 history starts 14 Jan 2019, so that benchmark is not plotted over this window — pick a shorter range to see it.
View as table
| Date | Edelweiss Large & Mid Cap Fund |
|---|---|
| 28 Nov 2016 | ₹100.00 |
| 20 Sep 2017 | ₹129.64 |
| 13 Jul 2018 | ₹141.46 |
| 05 May 2019 | ₹141.34 |
| 25 Feb 2020 | ₹156.94 |
| 17 Dec 2020 | ₹178.19 |
| 09 Oct 2021 | ₹253.69 |
| 01 Aug 2022 | ₹251.42 |
| 24 May 2023 | ₹268.00 |
| 15 Mar 2024 | ₹346.65 |
| 05 Jan 2025 | ₹438.14 |
| 28 Oct 2025 | ₹447.68 |
| 20 Aug 2026 | ₹469.38 |
| Metric | Edelweiss · Direct NAV ₹109.76 Very High risk ★★★★☆ | Category median Large & Mid Cap Fund · 36 funds |
|---|---|---|
| +7.44% | +6.71% | |
| +16.81% | +16.28% | |
| +15.18% | +15.15% | |
| — | +15.07% | |
| +17.23% | +15.33% | |
| +14.93% | — | |
| +18.36% | +17.48% | |
| +19.03% | +16.77% | |
| — | +16.31% | |
| Risk | ||
| 15.12% | 14.81% | |
| 0.68 | 0.61 | |
| 0.93 | 0.82 | |
| -34.92% | -35.67% | |
| Nifty Midcap 150 | — | |
| +0.72% | +0.30% | |
| 0.83 | 0.83 | |
| 85.8% | 84.1% | |
| 77.5% | 78.7% | |
| 0.68% | 1.07% | |
| ₹63.87Cr | ₹3,576Cr | |
| Up to 1.00% | — | |
| None | — | |
| ₹100 | — | |
| ₹100 | — | |
| 36% | 42% | |
| Trideep Bhattacharya · 4.7y | — | |
| 28 Nov 2016 | — | |
| 87 | — | |
| 23.4% | — | |
| 0.5% | — | |
Best marks the strongest value in a row, and only where the gap is bigger than noise — a near-tie is left unmarked rather than dressed up as a result. SIP XIRR is a ₹10,000/month instalment over 5 years of real NAV history. Nothing here is supplied by a fund house. For research only — not investment advice.